News
Research
Team
Publications
Join us!
Contact
Internal
Suresh Anaganti
Latest
MERTK-Targeting Antibody–Drug Conjugate Selectively Depletes M2 Tumor-Associated Macrophages and MERTK-Expressing Cancer Cells
Cite
×